Loading the company…
Loading the company…
Families: CGM & insulin pump management.
All companies · Product and company coverage
In the last ten years FDA made 1 decision for Deka Research & Development (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 1 procedure family, the most in 2025 (1). The latest was on 2025-04-02.
| Family | Decisions on record |
|---|---|
| CGM & insulin pump management | 1 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2025-04-02 | 510(k) | K250930 | twiist system |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Deka Research & Development.